Source:http://linkedlifedata.com/resource/umls/id/C1879492
NCI: A regimen consisting of doxorubicin, followed by cyclophosphamide, methotrexate, fluorouracil (CMF), used in the adjuvant setting for the treatment of breast cancer.
Download in:
View as
